retatrutide news today recency 3 just took a major step toward FDA approval, and the numbers are unlike anything we've seen from a weight-loss injection. In Eli Lilly's phase TRIUMPH-1 trial, participants on the highest Drug retatrutide helps people lower

Instead, research suggests these medications may actually provide some cancer-protective benefits, particularly through weight loss and other metabolic improvements

This is not merely a disclaimer

Within two years the FDA issued warnings that acute pancreatitis may be a potential AE based on post-marketing surveillance 17

Given the immunosuppressive features of cannabis smoke on lung macrophages, a similar response could occur, although more research is needed to understand the impact of cannabis smoke and cannabinoids on macrophage efferocytosis and whether such changes are beneficial or detrimental

Once you introduce a liquid, the clock starts ticking

Weight Loss Coverage Has Flatlined and Some Employers Are Cutting It Employer coverage of GLP-1s for weight loss sat at 36% in both 2025 and 2026 , after climbing from 26% in 2023